Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Hugues Sicotte"'
Autor:
Liewei Wang, Manish Kohli, Richard M. Weinshilboum, Raphael E. Jimenez, Alan H. Bryce, Rachel E. Carlson, Peter T. Vedell, Ying Li, David W. Hillman, Jason P. Sinnwell, Winston Tan, Michael Gormley, Vipul Bhargava, Scott M. Dehm, Sisi Qin, Krishna R. Kalari, Hugues Sicotte
Supplementary Data from Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08445d7f735763f5fece05df8a4c879d
https://doi.org/10.1158/1541-7786.22528131.v1
https://doi.org/10.1158/1541-7786.22528131.v1
Autor:
Liewei Wang, Manish Kohli, Richard M. Weinshilboum, Raphael E. Jimenez, Alan H. Bryce, Rachel E. Carlson, Peter T. Vedell, Ying Li, David W. Hillman, Jason P. Sinnwell, Winston Tan, Michael Gormley, Vipul Bhargava, Scott M. Dehm, Sisi Qin, Krishna R. Kalari, Hugues Sicotte
Supplementary Figure from Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ebdffb97d49c44f551ca374788dfe1b
https://doi.org/10.1158/1541-7786.22528122.v1
https://doi.org/10.1158/1541-7786.22528122.v1
Autor:
Liewei Wang, Manish Kohli, Richard M. Weinshilboum, Raphael E. Jimenez, Alan H. Bryce, Rachel E. Carlson, Peter T. Vedell, Ying Li, David W. Hillman, Jason P. Sinnwell, Winston Tan, Michael Gormley, Vipul Bhargava, Scott M. Dehm, Sisi Qin, Krishna R. Kalari, Hugues Sicotte
We identified resistance mechanisms to abiraterone acetate/prednisone (AA/P) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study.We analyzed whole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1749fb83e420dfa5cadae5f0fd8e604a
https://doi.org/10.1158/1541-7786.c.6545625.v1
https://doi.org/10.1158/1541-7786.c.6545625.v1
Autor:
Scott M. Dehm, Liewei Wang, Joshua M. Lang, Kevin A.T. Silverstein, Eric D. Wieben, Jin Jen, Brian A. Costello, Henry C. Pitot, Jorge F. Quevedo, Bruce W. Eckloff, Peter T. Vedell, Haojie Huang, Rafael Jimenez, Ho Thai, Hugues Sicotte, Liguo Wang, Rachel E. Carlson, Winston Tan, Tyson Clark, Ting Hon, Elizabeth Tseng, Yingming Li, Jamie M. Sperger, Rendong Yang, Christine Henzler, Jamie L. Van Etten, David W. Hillman, Yeung Ho, Manish Kohli
Purpose: Androgen receptor (AR) variant AR-V7 is a ligand-independent transcription factor that promotes prostate cancer resistance to AR-targeted therapies. Accordingly, efforts are under way to develop strategies for monitoring and inhibiting AR-V7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875c67d4c730ffa27f30addd230041a8
https://doi.org/10.1158/1078-0432.c.6525402
https://doi.org/10.1158/1078-0432.c.6525402
Autor:
Scott M. Dehm, Liewei Wang, Joshua M. Lang, Kevin A.T. Silverstein, Eric D. Wieben, Jin Jen, Brian A. Costello, Henry C. Pitot, Jorge F. Quevedo, Bruce W. Eckloff, Peter T. Vedell, Haojie Huang, Rafael Jimenez, Ho Thai, Hugues Sicotte, Liguo Wang, Rachel E. Carlson, Winston Tan, Tyson Clark, Ting Hon, Elizabeth Tseng, Yingming Li, Jamie M. Sperger, Rendong Yang, Christine Henzler, Jamie L. Van Etten, David W. Hillman, Yeung Ho, Manish Kohli
Supplementary Table 1: Baseline Characteristics of the Patients; Supplementary Table 2: Baseline RNA-seq Expression Levels for AR/ARVs (spliced reads per million); Supplementary Table 3: TaqMan Gene Expression Assays with Circulating Tumor Cells; Sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ffdf0b0351ff1db0ee720d4361162d
https://doi.org/10.1158/1078-0432.22463442.v1
https://doi.org/10.1158/1078-0432.22463442.v1
Autor:
Thomas A. Sellers, Fergus J. Couch, Rebecca Sutphen, Vijayalakshmi Shridhar, Joellen M. Schildkraut, Prema P. Peethambaram, Linda E. Kelemen, Catherine M. Phelan, Ya-Yu Tsai, David J. Duggan, Jeremy Chien, Robert Brown, Jenny Gross, Beth Y. Karlan, Lene Lundvall, Claus Høgdall, Evelyn Despierre, Diether Lambrechts, Arif B. Ekici, Peter A. Fasching, Susanne Krüger Kjær, Estrid Høgdall, Elaine A. Elliott, Michele M. Schmidt, Hugues Sicotte, David N. Rider, Sebastian M. Armasu, Katelyn E. Goodman, Xiaoqing Chen, Sharon E. Johnatty, Jonathan Beesley, Julie M. Cunningham, Trynda N. Oberg, Gary L. Keeney, Kristin L. White, Melissa C. Larson, Robert A. Vierkant, Kimberly R. Kalli, Brooke L. Fridley, Lynn C. Hartmann, Georgia Chenevix-Trench, Ellen L. Goode
Background: Invasive ovarian cancer is a significant cause of gynecologic cancer mortality.Methods: We examined whether this mortality was associated with inherited variation in approximately 170 candidate genes/regions [993 single-nucleotide polymor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338cc1759256ac819b975511d2b4faf9
https://doi.org/10.1158/1055-9965.c.6515776.v1
https://doi.org/10.1158/1055-9965.c.6515776.v1
Autor:
Thomas A. Sellers, Fergus J. Couch, Rebecca Sutphen, Vijayalakshmi Shridhar, Joellen M. Schildkraut, Prema P. Peethambaram, Linda E. Kelemen, Catherine M. Phelan, Ya-Yu Tsai, David J. Duggan, Jeremy Chien, Robert Brown, Jenny Gross, Beth Y. Karlan, Lene Lundvall, Claus Høgdall, Evelyn Despierre, Diether Lambrechts, Arif B. Ekici, Peter A. Fasching, Susanne Krüger Kjær, Estrid Høgdall, Elaine A. Elliott, Michele M. Schmidt, Hugues Sicotte, David N. Rider, Sebastian M. Armasu, Katelyn E. Goodman, Xiaoqing Chen, Sharon E. Johnatty, Jonathan Beesley, Julie M. Cunningham, Trynda N. Oberg, Gary L. Keeney, Kristin L. White, Melissa C. Larson, Robert A. Vierkant, Kimberly R. Kalli, Brooke L. Fridley, Lynn C. Hartmann, Georgia Chenevix-Trench, Ellen L. Goode
Supplementary Tables 1-7 from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c426ccacec416f32e09eae0bba39a5
https://doi.org/10.1158/1055-9965.22437196
https://doi.org/10.1158/1055-9965.22437196
Autor:
Thomas A. Sellers, Fergus J. Couch, Rebecca Sutphen, Vijayalakshmi Shridhar, Joellen M. Schildkraut, Prema P. Peethambaram, Linda E. Kelemen, Catherine M. Phelan, Ya-Yu Tsai, David J. Duggan, Jeremy Chien, Robert Brown, Jenny Gross, Beth Y. Karlan, Lene Lundvall, Claus Høgdall, Evelyn Despierre, Diether Lambrechts, Arif B. Ekici, Peter A. Fasching, Susanne Krüger Kjær, Estrid Høgdall, Elaine A. Elliott, Michele M. Schmidt, Hugues Sicotte, David N. Rider, Sebastian M. Armasu, Katelyn E. Goodman, Xiaoqing Chen, Sharon E. Johnatty, Jonathan Beesley, Julie M. Cunningham, Trynda N. Oberg, Gary L. Keeney, Kristin L. White, Melissa C. Larson, Robert A. Vierkant, Kimberly R. Kalli, Brooke L. Fridley, Lynn C. Hartmann, Georgia Chenevix-Trench, Ellen L. Goode
Supplementary Figures 1-4 from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51e4d5850e3989ba3dfe13001ab7ce4
https://doi.org/10.1158/1055-9965.22437199
https://doi.org/10.1158/1055-9965.22437199
Autor:
Reuben S. Harris, Scott H. Kaufmann, Hugues Sicotte, Ellen L. Goode, Kimberly R. Kalli, Lynn C. Hartmann, Elizabeth M. Swisher, Jeremy Chien, John Peden, Zoya Kingsbury, Sean Humphray, Russell Grocock, Jian-Bing Fan, R. Keira Cheetham, Marina Bibikova, David Bentley, Craig April, Debra A. Bell, Viji Shridhar, Julie M. Cunningham, Ann L. Oberg, Matthew J. Maurer, Yuji Zhang, Ying Li, William L. Brown, Emily K. Law, Jason B. Nikas, Rachel I. Vogel, Anurag Rathore, Nuri A. Temiz, Michael A. Carpenter, Michael B. Burns, Steven N. Hart, Brandon Leonard
PDF file - 481K, Table S1: Cell line information Table S2: Quantitative PCR primer and probe sequences. Table S3: Non-malignant tissues tested Table S4: Early stage serous ovarian tumors used in sequence analyses Table S5: Additional ovarian tumor sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::257df24e001a06c97dcee7ba0d83e354
https://doi.org/10.1158/0008-5472.22396406.v1
https://doi.org/10.1158/0008-5472.22396406.v1
Autor:
Liguo Wang, Steven N Hart, Marissa S Ellingson, Kim Schahl, Peter T Vedell, Rachel E Carlson, Jason P Sinnwell, Poulami Barman, Hugues Sicotte, Jeanette E Eckel-Passow, Krishna R Kalari, Rui Qin, Teresa M Kruisselbrink, Rafael E Jimenez, Alan H Bryce, Winston Tan, Richard Weinshilboum, Liewei Wang, Manish Kohli
Publikováno v:
BMJ Open, Vol 6, Iss 4 (2016)
Objectives To determine the frequency of pathogenic inherited mutations in 157 select genes from patients with metastatic castrate-resistant prostate cancer (mCRPC).Design Observational.Setting Multisite US-based cohort.Participants Seventy-one adult
Externí odkaz:
https://doaj.org/article/93e8446e31e44fcfb24c1cc42820ae4c